Organization | Field Name | ID | Required |
|---|---|---|---|
KCR | AJCC TNM Post Therapy Clin (yc) T (AjccTnmPostTherapyClinTSuffix) | 33173 | Yes |
AJCC | AJCC TNM Post Therapy Clin (yc) T Suffix | Yes |
Description
Identifies the AJCC TNM post therapy clinical T category suffix for the tumor following the completion of neoadjuvant therapy (satisfying the definition for that disease site) and before planned post- neoadjuvant therapy surgical resection. Stage suffices identify special cases that need separate analysis. Suffices are adjuncts to and do not change the stage group.
Rationale
The CoC requires that AJCC TNM staging be used in its accredited cancer programs. The CoC requires use of the current AJCC Staging System in its accredited program cancer registries when the planned post- neoadjuvant therapy surgery has been canceled. The AJCC developed this staging system for evaluating trends in the treatment and control of cancer. This staging system is used by physicians to estimate prognosis, plan treatment, evaluate new types of therapy, analyze outcomes, design follow-up strategies, and to assess early detection results.
Codes (as published in the AJCC 8th edition Cancer Staging Manual)
| (m) | Multiple synchronous tumors OR For thyroid differentiated and anaplastic only, Multifocal tumor |
| (s) | For thyroid differentiated and anaplastic only, Solitary tumor |
| Blank | No information available; not recorded |
Note: Refer to the current AJCC 8th edition Cancer Staging Manual for staging rules.
Overview
Content Tools
Activity